Design Therapeutics's total assets for Q3 2023 were $299.87M, a decrease of -3.77% from the previous quarter. DSGN total liabilities were $14.91M for the fiscal quarter, a 0.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.